COILED THERAPEUTICS PLC (COIL) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the Rockford Therapeutics PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the q and a tab situated in the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company will review all questions submitted today and publish responses where it is appropriate to do so. Before we begin, I'd like to submit the following poll. And I'd now like to hand you over to Steven West, executive chairman. Good afternoon, sir. Thank you, and good afternoon, everyone. Thanks for joining us today on our company update presentation. My name is Steve West. I'm the founder and chairman of Rockford Therapeutics, which is a material biotech company focused on the oncology space. I'm joined here today by our CEO, Adjane Reginald, He's gonna lead the presentation today and go through our growth plans. So without much further ado, I'll pass pass the presentation over to Adjan. Thanks, Adjan. Brilliant. Thanks, Steve. Good afternoon, everybody. So as Steve mentioned, this is an update presentation. So we're going to take you through a quick reminder of the company. So we'll start off with a snapshot. Rockfall was established in in 2020 by by Steve and the other founders. And in 2021, they acquired Lyramid, which is an exciting portfolio of therapeutics, which included the antibody MidKind Therapeutics, but also an oligotherapeutic for MidKind. And then in September of last year, Rock four acquired Oncogeny, which added two more families of innovative cancer medicines. One was the cell therapy, and the secon...